StocksFundsScreenerSectorsWatchlists
AMTX

AMTX - Aemetis Inc Stock Price, Fair Value and News

3.90USD0.00 (0.00%)Market Closed

Market Summary

AMTX
USD3.900.00
Market Closed
0.00%

AMTX Stock Price

View Fullscreen

AMTX RSI Chart

AMTX Valuation

Market Cap

166.2M

Price/Earnings (Trailing)

-3.58

Price/Sales (Trailing)

0.89

EV/EBITDA

-8.53

Price/Free Cashflow

-8.61

AMTX Price/Sales (Trailing)

AMTX Profitability

EBT Margin

-53.64%

Return on Equity

21.39%

Return on Assets

-19.07%

Free Cashflow Yield

-11.61%

AMTX Fundamentals

AMTX Revenue

Revenue (TTM)

186.7M

Rev. Growth (Yr)

6.04%

Rev. Growth (Qtr)

3.02%

AMTX Earnings

Earnings (TTM)

-46.4M

Earnings Growth (Yr)

-13.53%

Earnings Growth (Qtr)

-182.84%

Breaking Down AMTX Revenue

Last 7 days

0.3%

Last 30 days

-30.2%

Last 90 days

16.8%

Trailing 12 Months

80.9%

How does AMTX drawdown profile look like?

AMTX Financial Health

Current Ratio

0.43

Debt/Equity

-1.36

Debt/Cashflow

0.05

AMTX Investor Care

Shares Dilution (1Y)

16.25%

Diluted EPS (TTM)

-1.28

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2023239.1M221.6M204.2M186.7M
2022221.2M232.2M254.1M256.5M
2021168.9M175.9M184.9M211.9M
2020199.6M196.8M180.3M165.6M
2019170.4M176.0M188.7M202.0M
2018161.6M165.9M171.6M171.5M
2017141.4M149.1M148.7M150.2M
2016145.7M140.2M141.1M143.2M
2015181.7M163.1M153.2M147.1M
2014218.8M228.6M220.3M207.7M
2013164.3M167.3M170.6M177.5M
2012185.3M202.3M199.2M189.0M
2011000141.9M

Tracking the Latest Insider Buys and Sells of Aemetis Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Jan 18, 2024
mcafee eric a
acquired
-
-
300,000
chief executive officer
Jan 18, 2024
beebe lydia i
acquired
-
-
13,500
-
Jan 18, 2024
boness naomi louise
acquired
-
-
11,000
-
Jan 18, 2024
barton francis p
acquired
-
-
17,000
-
Jan 18, 2024
simon timothy alan
acquired
-
-
11,000
-
Jan 18, 2024
block john r
acquired
-
-
11,000
-
Sep 12, 2023
boness naomi louise
sold
-84,694
5.6463
-15,000
-
Jun 16, 2023
block john r
sold
-121,013
6.3011
-19,205
-
Jun 15, 2023
block john r
sold (taxes)
-180,405
6.84
-26,375
-
Jun 15, 2023
block john r
acquired
180,400
3.00667
60,000
-

1–10 of 50

Which funds bought or sold AMTX recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 23, 2024
FIFTH THIRD BANCORP
unchanged
-
1,125
8,985
-%
Apr 15, 2024
JANICZEK WEALTH MANAGEMENT, LLC
unchanged
-
232
1,857
-%
Apr 15, 2024
GoalVest Advisory LLC
unchanged
-
2,904
23,199
0.01%
Mar 22, 2024
PNC FINANCIAL SERVICES GROUP, INC.
added
131
2,149
3,270
-%
Mar 11, 2024
VANGUARD GROUP INC
added
3.59
2,080,730
8,836,910
-%
Mar 08, 2024
ICA Group Wealth Management, LLC
added
3.63
21,156
89,735
0.02%
Mar 01, 2024
GOLDMAN SACHS GROUP INC
added
152
257,773
375,426
-%
Feb 16, 2024
PRICE T ROWE ASSOCIATES INC /MD/
unchanged
-
11,000
53,000
-%
Feb 15, 2024
BARCLAYS PLC
added
87.72
207,000
357,000
-%
Feb 15, 2024
Farther Finance Advisors, LLC
new
-
5.00
5.00
-%

1–10 of 38

Are Funds Buying or Selling AMTX?

Are funds buying AMTX calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own AMTX
No. of Funds

Unveiling Aemetis Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
encompass capital advisors llc
4.43%
1,748,952
SC 13G/A
Feb 14, 2024
alliancebernstein l.p.
0.0%
0
SC 13G/A
Feb 13, 2024
grantham, mayo, van otterloo & co. llc
4.60%
1,815,264
SC 13G/A
Jul 07, 2023
blackrock inc.
1.5%
557,795
SC 13G/A
Feb 14, 2023
encompass capital advisors llc
5.1%
1,778,715
SC 13G/A
Feb 14, 2023
alliancebernstein l.p.
5.9%
2,082,191
SC 13G/A
Feb 13, 2023
grantham, mayo, van otterloo & co. llc
5.83%
2,043,443
SC 13G
Feb 01, 2023
blackrock inc.
6.4%
2,259,358
SC 13G/A
Jan 20, 2023
state street corp
1.76%
618,031
SC 13G/A
May 09, 2022
blackrock inc.
10.1%
3,454,569
SC 13G

Recent SEC filings of Aemetis Inc

View All Filings
Date Filed Form Type Document
Apr 19, 2024
PRE 14A
PRE 14A
Mar 29, 2024
10-K
Annual Report
Mar 29, 2024
S-8
Employee Benefits Plan
Mar 15, 2024
NT 10-K
NT 10-K
Mar 07, 2024
8-K
Current Report
Feb 20, 2024
8-K
Current Report
Feb 16, 2024
8-K
Current Report
Feb 14, 2024
8-K
Current Report
Feb 14, 2024
SC 13G/A
Major Ownership Report
Feb 14, 2024
SC 13G/A
Major Ownership Report

Peers (Alternatives to Aemetis Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
480.3B
344.6B
6.63% 2.38%
13.34
1.39
-16.70% -35.40%
303.9B
200.9B
5.29% -5.04%
14.22
1.51
-18.40% -39.75%
59.2B
28.9B
5.61% 7.38%
12.61
2.05
-22.04% -64.70%
15.9B
6.6B
2.69% 12.54%
10.22
2.39
-17.41% -56.98%
11.9B
8.7B
2.61% 7.38%
4.9
1.36
-25.73% -50.99%
MID-CAP
8.5B
2.2B
10.15% 42.39%
17.6
3.86
-62.59% -77.29%
4.2B
2.8B
2.54% 14.07%
9.7
1.48
19.47% 177.97%
3.7B
3.4B
5.94% 53.51%
2.13
1.07
172.35% 1311.12%
2.8B
1.7B
0.34% -14.77%
13.14
1.65
-26.01% -5.75%
2.4B
2.1B
12.10% 1.07%
5.93
1.13
-35.04% -60.65%
SMALL-CAP
289.7M
307.6M
16.98% 4.99%
0.74
0.94
-32.91% 578.62%
166.2M
186.7M
-30.16% 80.93%
-3.58
0.89
-27.21% 56.92%
84.1M
220.8M
-8.07% -26.71%
-27.59
0.38
-38.52% -116.44%
75.2M
2.7B
13.76% -21.15%
354.73
0.03
-18.46% -93.92%
27.2M
23.9M
18.14% 3.70%
-10.01
1.14
-21.86% -149.09%

Aemetis Inc News

Latest updates
MarketBeat • 14 Apr 2024 • 11:52 am
InvestorsObserver • 27 Mar 2024 • 07:00 am
Yahoo Finance • 22 Mar 2024 • 07:00 am
InvestorsObserver • 21 Mar 2024 • 07:00 am
CNN • 19 Mar 2024 • 12:58 am
Yahoo Finance • 14 Mar 2024 • 07:00 am
Seeking Alpha • 07 Mar 2024 • 08:00 am
Seeking Alpha • 02 Mar 2024 • 08:00 am

Aemetis Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue3.0%70,764,00068,690,00045,112,00055,922,00066,732,00071,831,00065,901,00052,049,00064,363,00049,895,00054,884,00042,807,00037,330,00040,923,00047,824,00039,480,00052,102,00057,389,00050,619,00041,888,00038,845,000
Gross Profit75.6%864,000492,0001,956,000-1,295,000-1,132,000-1,104,000-214,000-3,085,00012,686,000-4,785,0003,646,000-3,608,000-3,372,000771,00014,059,000-433,0005,794,0003,982,0003,273,000-351,000-1,897,000
  S&GA Expenses8.9%9,786,0008,985,0009,709,00010,786,0007,520,0006,439,0007,421,0007,306,0007,454,0005,087,0005,753,0005,382,0004,334,0004,563,0004,049,0003,936,0004,709,0004,529,0003,945,0004,241,0004,796,000
  R&D Expenses2.8%37,00036,00037,00042,00041,00052,00051,00036,00022,00022,00021,00023,00038,00037,00021,000117,00045,00037,00090,00033,00055,000
EBITDA Margin-12.8%-0.29-0.25-0.44-0.32-0.28-0.22-0.04-0.09-0.080.010.050.13---------
Interest Expenses75.9%15,393,0008,749,0008,299,0007,078,00013,951,0005,456,0004,928,0004,435,0009,155,0004,408,0004,529,0005,965,0005,987,0005,796,0005,574,0005,586,0005,517,0005,396,0005,190,0004,986,00012,295,000
Income Taxes101.4%754,000-55,308,0001,066,000-248,0001,040,0003,0003,0007,000-135,000--7,000-713,000--56,000-207,0001,124,000--7,0001,000
Earnings Before Taxes-0.4%-24,688,000-24,597,000-24,213,000-26,658,000-21,370,000-66,842,000-206,000-18,287,000-1,016,000-17,597,000-10,557,000-18,105,00022,340,000-12,217,0002,136,000-12,259,00031,816,000-7,226,000-13,930,000-10,660,000-12,310,000
EBT Margin-13.1%-0.54-0.47-0.63-0.48-0.42-0.34-0.16-0.21-0.22-0.13-0.11-0.03---------
Net Income-182.8%-25,442,00030,711,000-25,279,000-26,410,000-22,410,000-66,845,000-209,000-18,294,000-881,000-17,597,000-10,557,000-18,112,000-14,582,000-12,217,0002,192,000-12,052,000-7,654,000-7,226,000-13,930,000-10,667,000-12,311,000
Net Income Margin-17.0%-0.25-0.21-0.64-0.48-0.42-0.34-0.16-0.21-0.22-0.33-0.32-0.25---------
Free Cashflow230.0%19,439,000-14,948,000-4,911,000-18,874,000-16,785,000-16,237,000-11,390,000-17,611,000-8,535,000-7,616,000-10,515,000-20,633,000---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets-12.3%24327721321020719917816616114714314412512212210410097.0092.0092.0092.00
  Current Assets-53.6%36.0078.0021.0021.0018.0024.0015.0016.0021.0017.0019.0024.009.0014.0018.0010.0013.0013.0010.0010.0010.00
    Cash Equivalents-31.6%3.004.003.004.004.000.004.005.008.006.007.0016.001.000.003.000.001.001.000.000.001.00
  Inventory124.6%18.008.007.0013.005.0010.005.005.005.005.005.004.004.005.007.005.007.004.004.006.006.00
  Net PPE3.7%19518818318118016915714513512511911311010399.0091.0084.0081.0079.0078.0078.00
  Current Liabilities-26.2%84.0011410910488.0018360.0063.0065.0075.0063.0066.0010296.0060.0061.0058.0058.0058.0050.0043.00
  Short Term Borrowings-44.7%23.0042.0041.0045.0037.0019.0016.0015.0015.0014.0014.0014.0015.0017.0016.0017.0017.0017.0017.0017.0015.00
  Long Term Debt-295-------190---7.00---138---158
    LT Debt, Current-43.6%14.0024.0021.0017.0012.0010.009.008.008.0010.0010.0012.0045.0042.008.006.006.005.005.005.002.00
    LT Debt, Non Current-258---197----------------
Shareholder's Equity-Infinity%-216----201----120-----------116
  Retained Earnings-5.7%-475-449-480-455-428-406-339-339-321-320-302-292-274-259-247-249-237-222-215-202-193
  Additional Paid-In Capital3.3%26425624723823322722221520519318315893.0088.0088.0087.0087.0087.0086.0086.0086.00
Shares Outstanding4.0%41.0039.0038.0037.0036.0035.0034.0034.0033.0030.0029.0026.00---------
Minority Interest-------------------7.57-6.67-5.68-4.74
Float---253---146---302*---15.00---11.00--
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations651.3%33,963-6,161-2,719-11,258-6,559-9,8241,669-8,152-654-1,780-4,140-14,073-4,5762,1984,248610-908105876-2,107-2,152
  Share Based Compensation-20.4%1,4371,8061,7552,6621,4761,5451,3492,0402,527285281835169191325310144144196290198
Cashflow From Investing-51.9%-12,774-8,407-1,647-859-9,776-5,159-8,379-7,992-5,347-5,836-6,342-5,3691,299-9,987-6,249-2,372-3,525-4,015-440-598-1,576
Cashflow From Financing-236.9%-22,50616,4363,77111,39323,24511,6834,82713,8787,3566,8221,89534,6313,7894,4495,1171,4204,1664,494-1341,5594,856

AMTX Income Statement

2023-12-31
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenues$ 186,717$ 256,513
Cost of goods sold184,700262,048
Gross (loss) profit2,017(5,535)
Research and development expenses152180
Selling, general and administrative expenses39,26628,686
Operating loss(37,401)(34,401)
Other expense (income):  
Interest rate expense32,99521,407
Debt related fees and amortization expense6,5247,363
Accretion and other expenses of Series A preferred units25,3139,888
Loss on debt extinguishment049,386
Gain on litigation0(1,400)
Other income(2,077)(14,340)
Loss before income taxes(100,156)(106,705)
Income tax expense (benefit)(53,736)1,053
Net loss(46,420)(107,758)
Other comprehensive (loss)  
Foreign currency translation loss(219)(1,102)
Comprehensive loss$ (46,639)$ (108,860)
Net loss per common share  
Basic (in dollars per share)$ (1.22)$ (3.12)
Diluted (in dollars per share)$ (1.22)$ (3.12)
Weighted average shares outstanding  
Basic (in shares)38,06134,585
Diluted (in shares)38,06134,585

AMTX Balance Sheet

2023-12-31
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 2,667$ 4,313
Accounts receivable8,6331,264
Inventories, net of allowance for excess and obsolete inventory of $1,040 as of December 31, 2023 and 202218,2914,658
Prepaid expenses3,3474,248
Other current assets3,4623,653
Total current assets36,40018,136
Property, plant and equipment, net195,108180,441
Operating lease right-of-use assets2,0562,449
Other assets9,8426,088
Total assets243,406207,114
Current liabilities:  
Accounts payable32,13226,168
Current portion of long term debt13,58512,465
Short term borrowings23,44336,754
Current portion of operating lease liability406338
Other current liabilities10,3028,474
Total current liabilities84,38988,281
Long term liabilities:  
Senior secured notes and revolving notes176,476155,843
EB-5 notes29,50029,500
Other long term debt51,71711,678
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent113,200116,000
Operating lease liability1,7832,189
Other long term liabilities3,3295,477
Total long term liabilities375,994320,687
Stockholders' deficit:  
Common stock, $0.001 par value; 80,000 authorized; 40,966 and 35,869 shares issued and outstanding each period, respectively4136
Additional paid-in capital264,058232,546
Accumulated deficit(475,405)(428,985)
Accumulated other comprehensive loss(5,671)(5,452)
Total stockholders' deficit(216,977)(201,854)
Total liabilities and stockholders' deficit243,406207,114
Series B Convertible Preferred Stock [Member]  
Stockholders' deficit:  
Series B convertible preferred stock, $0.001 par value; 7,235 authorized; 0 and 1,270 shares issued and outstanding each period, respectively (aggregate liquidation preference of $0 and $3,810 respectively)01
Convertible Series B Preferred Stock Subject to Mandatory Redemption [Member]  
Current liabilities:  
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Current4,5214,082
Convertible Series A Preferred Stock Subject to Mandatory Redemption [Member]  
Long term liabilities:  
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent$ 113,189$ 116,000
AMTX
Aemetis, Inc. operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the acquisition, development, and commercialization of negative carbon intensity products and technologies that replace traditional petroleum-based products. In addition, it produces and sells ethanol; and wet distillers grains, distillers corn oil, and condensed distillers solubles to dairies and feedlots as animal feed. Further, the company markets and supplies high-grade alcohol and hand sanitizer. Additionally, it researches and develops conversion technologies using waste feedstocks to produce biofuels and biochemicals. Furthermore, it sells biodiesel primarily to government oil marketing companies, transport companies, resellers, distributors, and private refiners through its own sales force and independent sales agents, as well as to brokers who resell the product to end-users. Aemetis, Inc. was founded in 2005 and is headquartered in Cupertino, California.
 CEO
 WEBSITEaemetis.com
 INDUSTRYOil - E&P
 EMPLOYEES167

Aemetis Inc Frequently Asked Questions


What is the ticker symbol for Aemetis Inc? What does AMTX stand for in stocks?

AMTX is the stock ticker symbol of Aemetis Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Aemetis Inc (AMTX)?

As of Tue Apr 23 2024, market cap of Aemetis Inc is 166.17 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AMTX stock?

You can check AMTX's fair value in chart for subscribers.

What is the fair value of AMTX stock?

You can check AMTX's fair value in chart for subscribers. The fair value of Aemetis Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Aemetis Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AMTX so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Aemetis Inc a good stock to buy?

The fair value guage provides a quick view whether AMTX is over valued or under valued. Whether Aemetis Inc is cheap or expensive depends on the assumptions which impact Aemetis Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AMTX.

What is Aemetis Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 23 2024, AMTX's PE ratio (Price to Earnings) is -3.58 and Price to Sales (PS) ratio is 0.89. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AMTX PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Aemetis Inc's stock?

In the past 10 years, Aemetis Inc has provided 0.264 (multiply by 100 for percentage) rate of return.